Patents by Inventor Diane SAUNDERS

Diane SAUNDERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of creating secure endpoints on a network
    Patent number: 12225017
    Abstract: A method of creating secure endpoints on a network includes registering by a node using a random selection algorithm to choose which server to register to; receiving by the node a property set ID of a property set that the node is a member of; and authorizing by the node using the property set ID to look up its authorization details in the property set. A method of creating secure endpoints on a secure network having at least one community of interest, includes registering by a node using a random selection algorithm to choose which server to register to; receiving by the node a property set ID of a property set that the node is a member of; and authorizing by the node through an authorization server using the property set ID to look up its authorization details in the property set; wherein the node and the authorization server are a member of the at least one community of interest.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: February 11, 2025
    Assignee: UNISYS CORPORATION
    Inventors: Jared Poetter, Michael C Leap, Diane E Schaefer, Robert A Johnson, Michael Saunders, Robert R Buckwalter, Sarah K Inforzato, Eugene J Gretter, George Karian
  • Application of anti-CD39L3 antibodies for use in disease diagnostics and imaging
    Patent number: 11287427
    Abstract: In spite of significant efforts to identify ?-cell-specific markers for ?-cell imaging and purification, progress has been limited. Herein is disclosed a novel biomarker of human pancreatic ?-cells, CD39L3 (also known as ectonucleoside triphosphate diphosphohydrolase-3 (NTPDase3)). Disclosed are compositions and methods for purifying and imaging ?-cell using anti-CD39L3 antibodies.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: March 29, 2022
    Assignees: VANDERBILT UNIVERSITY, THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Alvin C. Powers, Marcela Brissova, Chunhua Dai, Neil Phillips, Diane Saunders
  • APPLICATION OF ANTI-CD39L3 ANTIBODIES FOR USE IN DISEASE DIAGNOSTICS AND IMAGING
    Publication number: 20200191787
    Abstract: In spite of significant efforts to identify ?-cell-specific markers for ?-cell imaging and purification, progress has been limited. Herein is disclosed a novel biomarker of human pancreatic ?-cells, CD39L3 (also known as ectonucleoside triphosphate diphosphohydrolase-3 (NTPDase3)). Disclosed are compositions and methods for purifying and imaging ?-cell using anti-CD39L3 antibodies.
    Type: Application
    Filed: June 11, 2018
    Publication date: June 18, 2020
    Inventors: Alvin C. POWERS, Marcela BRISSOVA, Chunhua DAI, Neil PHILLIPS, Diane SAUNDERS